Ospemifene is a selective estrogen receptor modulator (SERM) used primarily for the treatment of moderate to severe dyspareunia (painful intercourse) due to vulvovaginal atrophy (VVA) in postmenopausal women. It acts by binding to estrogen receptors, exerting estrogen-like effects on vaginal tissues while offering anti-estrogenic effects on breast tissues.
